video Video
Pfizer's bid is too bitter for Astra
Monday, May 19, 2014 - 02:21
May.19 - Britain's AstraZeneca has rejected a sweetened offer from Pfizer. But could they live to regret turning down the U.S. drugmaker's plan to create the world's biggest pharmaceuticals group? Ciara Sutton reports
▲ Hide Transcript
▶ View Transcript
At almost 70 billion pounds it would have been the largest ever foreign acquisition of a British company. But AstraZeneca has rejected Pfizer's new "take it or leave it" offer of 55 pounds a share. The deal had faced fierce opposition from UK politicians who feared it would undermine Britain's science base. Pfizer's motivation was also questioned - many seeing it as a way to avoid paying high U.S. taxes. BGC's Mike Ingram says that also raised eyebrows in the States. (SOUNDBITE) (English) BGC MARKET COMMENTATOR, MIKE INGRAM, SAYING: "We've already had a couple of U.S. senators seeking to close the tax inversion loophole which Pfizer will be looking to employ if it did go ahead with a takeover of AstraZeneca. Maybe other than a cooling off of the M&A mania we've seen is perhaps eventually lower corporate tax rates in the U.S. It does seem to be somewhat out of step with the rest of the world now being at 35 percent" AstraZeneca's management was always firmly against a deal. Last week its CEO told UK lawmakers it could disrupt its research and possibly even cost lives. (SOUNDBITE) (English) ASTRAZENECA CHIEF EXECUTIVE OFFICER, PASCAL SORIOT, SAYING: "What will we tell the person whose father died from lung cancer because one of our medicines was delayed - and essentially was delayed because in the meantime our two companies were involved in saving tax and saving costs?" There are also concerns the cost-cutting involved in such a large takeover would lead to less drug making. Pfizer has a tarnished reputation in Britain - where it created the drug Viagra - because it shut down most of its research operations and slashed 1700 jobs. But AstraZeneca's shares tumbled 13% after the rejection - investors could yet influence the outcome. (SOUNDBITE) (English) BGC MARKET COMMENTATOR, MIKE INGRAM, SAYING: "I think they have probably been over aggressive I can't imagine shareholders today are going to be very happy with them and I suspect they are going to be urging them to come back to the table and open the books to Pfiizer in order to try and get a somewhat improved offer." Pfizer has promised it won't make a hostile offer directly to AstraZeneca shareholders. But if with the number of disgruntled investors grows, the company's board could be forced back to the negotiating table.
Press CTRL+C (Windows), CMD+C (Mac), or long-press the URL below on your mobile device to copy the code
Pfizer's bid is too bitter for Astra
Monday, May 19, 2014 - 02:21
Top News »
10:29am EDT - (1:29)
9:22am EDT - (1:06)
8:37am EDT - (2:01)
Sat, Apr 21, 2018 - (0:32)
Sat, Apr 21, 2018 - (0:44)
Sat, Apr 21, 2018 - (1:18)
Sat, Apr 21, 2018 - (2:00)
Sat, Apr 21, 2018 - (1:58)
Sat, Apr 21, 2018 - (1:03)
Sat, Apr 21, 2018 - (1:03)
Sat, Apr 21, 2018 - (1:22)
Fri, Apr 20, 2018 - (1:31)
Migrant Crisis »
Fri, Mar 16, 2018 - (0:50)
Fri, Dec 22, 2017 - (1:52)
Fri, Dec 22, 2017 - (1:07)
Fri, Dec 22, 2017 - (1:37)
Editors' Picks »
Fri, Apr 20, 2018 - (1:24)
Fri, Apr 20, 2018 - (2:04)
Thu, Apr 19, 2018 - (0:57)
Thu, Apr 19, 2018 - (1:45)
Tue, Apr 17, 2018 - (2:44)
Tue, Apr 17, 2018 - (2:15)
Mon, Apr 16, 2018 - (1:59)
Fri, Apr 13, 2018 - (1:09)
Fri, Apr 13, 2018 - (2:15)
Fri, Apr 13, 2018 - (1:40)
Politics »
Fri, Apr 20, 2018 - (1:07)
Fri, Apr 20, 2018 - (1:46)
Thu, Apr 19, 2018 - (2:16)
Thu, Apr 19, 2018 - (1:32)
Thu, Apr 19, 2018 - (1:00)
Thu, Apr 19, 2018 - (0:32)
Thu, Apr 19, 2018 - (1:37)
Wed, Apr 18, 2018 - (0:58)
Wed, Apr 18, 2018 - (0:35)
Wed, Apr 18, 2018 - (0:45)
Innovations »
4:41am EDT - (1:30)
Fri, Apr 20, 2018 - (1:50)
Thu, Apr 19, 2018 - (1:54)
Wed, Apr 18, 2018 - (1:03)
Wed, Apr 18, 2018 - (1:01)
Tue, Apr 17, 2018 - (2:15)
Mon, Apr 16, 2018 - (1:54)
Mon, Apr 16, 2018 - (0:50)
Fri, Apr 13, 2018 - (2:15)
Thu, Apr 12, 2018 - (1:41)
Entertainment »
Sat, Apr 21, 2018 - (0:32)
Fri, Apr 20, 2018 - (1:24)
Fri, Apr 20, 2018 - (1:47)
Fri, Apr 20, 2018 - (0:59)
Fri, Apr 20, 2018 - (0:46)
Fri, Apr 20, 2018 - (1:31)
Fri, Apr 20, 2018 - (2:10)
Fri, Apr 20, 2018 - (0:49)
Thu, Apr 19, 2018 - (1:19)
Thu, Apr 19, 2018 - (1:27)
Rough Cuts »
Fri, Apr 20, 2018 - (0:57)
Fri, Apr 20, 2018 - (0:43)
Thu, Apr 19, 2018 - (0:54)
Thu, Apr 19, 2018 - (0:55)
Thu, Apr 19, 2018 - (2:09)
Thu, Apr 19, 2018 - (1:22)
Thu, Apr 19, 2018 - (2:22)
Thu, Apr 19, 2018 - (0:32)
Thu, Apr 19, 2018 - (1:31)
Thu, Apr 19, 2018 - (1:36)
Wed, Apr 18, 2018 - (0:58)
Wed, Apr 18, 2018 - (1:37)
Moving Pictures »
Tue, Apr 03, 2018 - (1:46)
Fri, Mar 02, 2018 - (2:13)
Thu, Feb 08, 2018 - (1:43)
Thu, Jan 04, 2018 - (1:01)
Fri, Dec 22, 2017 - (2:08)
Reuters Investigates »
Wed, Oct 11, 2017 - (10:18)
Wed, Aug 23, 2017 - (6:44)
Thu, Mar 16, 2017 - (2:26)
Tue, Nov 01, 2016 - (2:15)
Thu, Sep 29, 2016 - (2:19)
Fri, Aug 05, 2016 - (2:04)
Mon, Mar 28, 2016 - (3:02)
Thu, Mar 10, 2016 - (2:34)
Mon, Dec 07, 2015 - (2:58)
Mon, Dec 07, 2015 - (2:20)
Mon, Dec 07, 2015 - (0:35)
Mon, Dec 07, 2015 - (3:53)
Dateline Asia »
Tue, Dec 05, 2017 - (2:06)
Tue, Dec 05, 2017 - (2:11)
Fri, Dec 01, 2017 - (2:04)
Thu, Nov 30, 2017 - (2:10)
Thu, Nov 30, 2017 - (2:14)
Wed, Nov 29, 2017 - (2:11)
Tue, Nov 28, 2017 - (1:55)
Tue, Nov 28, 2017 - (2:21)
Mon, Nov 27, 2017 - (2:25)
Fri, Nov 24, 2017 - (2:16)
Fri, Nov 24, 2017 - (2:14)
Thu, Nov 23, 2017 - (2:18)